What follows is an outsider's report on the next big phase of cardiology—the percutaneous treatment of valvular heart disease. I have little doubt that in 5 to 10 years, transcutaneous valves will be ...
Two year outcomes in a study comparing transcatheter to surgical bioprosthetic aortic valve implantation, shows that the less invasive procedure is safe and effective, and comparable to the gold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback